2006
DOI: 10.1073/pnas.0506982103
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

Abstract: Farnesoid X receptor (FXR) plays an important role in maintaining bile acid and cholesterol homeostasis. Here we demonstrate that FXR also regulates glucose metabolism. Activation of FXR by the synthetic agonist GW4064 or hepatic overexpression of constitutively active FXR by adenovirus-mediated gene transfer significantly lowered blood glucose levels in both diabetic db͞db and wild-type mice. Consistent with these data, FXR null mice exhibited glucose intolerance and insulin insensitivity. We further demonstr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

42
712
7
12

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 815 publications
(773 citation statements)
references
References 52 publications
42
712
7
12
Order By: Relevance
“…Acute elevation of bile acids decreases liver triglycerides, 40 and synthetic FXR agonists also lower TG levels. 41 Thus, acute induction of SHP expression via the FXR pathway and either transgenic or adenoviral SHP overexpression have essentially the opposite effect on lipid accumulation. In addition, FXR Ϫ/Ϫ livers accumulate TGs despite decreased SHP expression.…”
Section: Discussionmentioning
confidence: 99%
“…Acute elevation of bile acids decreases liver triglycerides, 40 and synthetic FXR agonists also lower TG levels. 41 Thus, acute induction of SHP expression via the FXR pathway and either transgenic or adenoviral SHP overexpression have essentially the opposite effect on lipid accumulation. In addition, FXR Ϫ/Ϫ livers accumulate TGs despite decreased SHP expression.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that FXR agonists should cause weight loss in diet-induced obese mice. Inconsistent results have been obtained with such compounds, however [81,82,83]. Recently, the gut-restricted FXR agonist fexaramine has been reported to reduce obesity and insulin resistance in mice.…”
Section: Mimicry Of Bariatric Surgerymentioning
confidence: 99%
“…Thus, there is circumstantial evidence to link the activity of FXR to the regulation of bile acid synthesis from cholesterol, providing a link between nutrient absorption and regulation of key steps in the intermediate metabolism. In addition, because bile acids might be toxic for the liver, activation of FXR by natural and synthetic ligands has been shown to prevent bile acid-induced liver toxicity in a variety of rodent models (33)(34)(35)(36)(37)(38)(39). The homeostatic function of FXR in the liver is highlighted by the demonstration that mice harboring a disrupted FXR (FXR Ϫ/Ϫ ) develop spontaneously an array of hepatocellular abnormalities including adenomas and carcinomas.…”
mentioning
confidence: 99%